Article
A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
Antimicrobial agents and chemotherapy - 1 Oct 2012
Passalacqua Karla D, Satola Sarah W, Crispell Emily K, Read Timothy D
Abstract excerpt
Methicillin-resistant Staphylococcus aureus (MRSA) strains with reduced susceptibility to vancomycin (MIC of 4 to 8 μg/ml) are referred to as vancomycin-intermediate S. aureus (VISA). In this study, we characterized two isogenic USA300 S. aureus isolates collected sequentially from a single patient with endocarditis where the S. aureus isolate changed from being susceptible to vancomycin (VSSA) (1 μg/ml) to VISA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
